SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-005316
Filing Date
2021-05-13
Accepted
2021-05-13 20:35:17
Documents
1
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3959
  Complete submission text file 0001179110-21-005316.txt   5347
Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 21921559

Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)